Wutah dodolan taun lumaku: Upstream Bio Inc (UPB)
Upstream Bio Inc (UPB) faces geopolitical risks regarding patent protection and is managing capital expenditure during the testing of immunotherapeutic drugs. The GURU.Markets system provides the annual revenue growth trend over a rolling 12-month period, where 2.60 characterizes this valuation parameter. Business development relies on partnerships with laboratories to create medications for allergies and asthma.
Upstream Pharma (UPB) - rincian metrik lan laporan keuangan
- rega pasar lan target rega analis:
- indikator kapitalisasi bursa perusahaan:
- indikator kapitalisasi buku:
- data tingkat utang lan likuiditas finansial:
Rasio Kabeh Utang marang Dana Pribadi Upstream Bio Inc|UPB - Utang jangka dawa marang modal|Kewajiban jangka cendhak marang modal Upstream Bio|UPB - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Upstream Bio, Inc.|UPB - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Upstream Bio|Rasio jangkoan perantara upstreambio.com
- indikator profitabilitas perusahaan lan kelipatan valuasi:
UPB - Bathi resik|Bathi sing dikarepake Upstream Bio Inc|UPB - Pangali P/E|Kapitalisasi marang proyeksi bathi upstreambio.com|UPB - Rasio rega marang bathi tumrap wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Upstream Bio Corp|UPB - Bathi operasional sadurunge ngurangi amortisasi|Bathi saben saham sajroning taun lumaku Upstream Bio|UPB - Bathi resik saben saham (EPS TTM)|Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan upstreambio.com|UPB - Wutah bathi saben saham ing taun lumaku|Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep Upstream Bio Inc
- indikator dodolan lan pendapatan:
Ringkesan analitik perusahaan:UPB (Upstream Pharma)
To minimize fundamental risks, investors should select assets with sustainable revenue expansion, which this metric calculates as the percentage change in total income over the last twelve months relative to the same period last year. In the context of immune drug development, Upstream Bio Inc (UPB) operating revenue growth YoY (TTM) reflects the commercial efficiency of innovations and the success of clinical trials.
Pesaing Upstream Bio Inc (UPB)
Argenx (ARGX) - Wutah pendapatan taun lumaku|BioNTech SE - Wutah dodolan YoY (TTM)|ABVX - Wutah dodolan YoY (TTM)|ADMA: Wutah dodolan YoY (TTM)|Protagonist Therapeutics, Inc. - Dinamika pendapatan YoY sajrone rolas wulan kepungkur|Wutah dodolan YoY sajrone rolas wulan kepungkur Immunovant Therapeutics|Wutah dodolan YoY sajrone 12 wulan kepungkur KNSA (Kiniksa Pharmaceuticals Ltd)|Wutah dodolan YoY (TTM) GRFS|ADPT: Wutah dodolan taun lumaku|Wutah dodolan YoY (TTM) CLDX (Celldex)|AUPH: Wutah dodolan YoY sajrone 12 wulan kepungkur|BCRX: Wutah pendapatan YoY sajrone 12 wulan kepungkur|Vera Pharma - Owah-owahan pendapatan YoY sajrone 12 wulan kepungkur|DNTH (Dianthus Corp) - Wutah pendapatan YoY sajrone 12 wulan kepungkur|Pharvaris N.V. - Dinamika pendapatan YoY sajrone rolas wulan kepungkur|Wutah dodolan YoY sajrone rolas wulan kepungkur AbCellera Biologics|Tourmaline Bio Inc (TRML) - Wutah pendapatan taunan sajrone rolas wulan kepungkur|Wutah pendapatan YoY sajrone 12 wulan kepungkur PGEN (Intrexon)|PHAR (Pharming) - Dinamika pendapatan YoY sajrone rolas wulan kepungkur|Wutah dodolan YoY (TTM) NKTR (Nektar Therapeutics Inc)|ZBIO (Zenas Biopharma Inc) - Wutah dodolan taun lumaku|IMNM - Wutah dodolan YoY sajrone rolas wulan kepungkur|Wutah pendapatan taunan sajrone rolas wulan kepungkur Gossamer Bio Inc GOSS|KALV: Wutah dodolan YoY (TTM)|Wutah pendapatan YoY sajrone 12 wulan kepungkur Septerna Pharma|PVLA (Pieris Corp) - Wutah dodolan YoY (TTM)|Wutah dodolan YoY sajrone rolas wulan kepungkur SVRA|Wutah dodolan YoY (TTM) RIGL|Wutah pendapatan YoY sajrone 12 wulan kepungkur AnaptysBio Corp ANAB|Astria Therapeutics Inc - Wutah pendapatan YoY sajrone 12 wulan kepungkur|Wutah pendapatan taunan sajrone rolas wulan kepungkur enGene Holdings Inc. (ENGN)|RAPT Therapeutics Inc. - Wutah dodolan YoY (TTM)|Wutah pendapatan taun lumaku Aerovate Therapeutics, Inc.|ACRS (Aclaris Therapeutics) - Wutah pendapatan YoY sajrone 12 wulan kepungkur|KYTX: Owah-owahan pendapatan YoY sajrone 12 wulan kepungkur|Wutah dodolan YoY sajrone rolas wulan kepungkur Tiziana Life Sciences|Cabaletta Bio, Inc (CABA) - Wutah pendapatan taunan sajrone rolas wulan kepungkur|Wutah pendapatan YoY sajrone 12 wulan kepungkur VTYX (Ventyx Biosciences)|Wutah pendapatan taunan sajrone rolas wulan kepungkur theratech.com|Wutah dodolan YoY (TTM) AVTX (Avalo Therapeutics, Inc.)|Wutah dodolan YoY (TTM) Eledon Pharmaceuticals Inc. ELDN|AGEN: Wutah pendapatan YoY sajrone 12 wulan kepungkur|Dinamika pendapatan YoY sajrone rolas wulan kepungkur CLYM (Climb Bio, Inc)|ZURA: Wutah dodolan YoY (TTM)|aTyr Pharma, Inc. - Dinamika pendapatan YoY sajrone rolas wulan kepungkur|Wutah dodolan YoY sajrone rolas wulan kepungkur Adagene Inc.|IMA: Dinamika pendapatan YoY sajrone rolas wulan kepungkur|Wutah dodolan YoY (TTM) STTK|Wutah pendapatan YoY sajrone 12 wulan kepungkur Equillium Bio EQ|Wutah dodolan YoY sajrone rolas wulan kepungkur Connect Biopharma CNTB|IMUX - Wutah pendapatan YoY sajrone 12 wulan kepungkur|ATRA - Wutah dodolan YoY sajrone rolas wulan kepungkur|InflaRx NV (IFRX) - Wutah pendapatan YoY sajrone 12 wulan kepungkur|XFOR (X4 Pharmaceuticals Inc.) - Wutah pendapatan YoY sajrone 12 wulan kepungkur|Wutah pendapatan taun lumaku Adicet Bio Inc. (ACET)|Wutah dodolan YoY sajrone rolas wulan kepungkur celularity.com|Wutah pendapatan YoY sajrone 12 wulan kepungkur inmunebio.com (INMB)|Wutah dodolan YoY sajrone rolas wulan kepungkur Barinthus Biotherapeutics PLC (BRNS)|Wutah pendapatan taunan sajrone rolas wulan kepungkur Kezar Life Sciences Inc.|SAB Biotherapeutics, Inc - Wutah pendapatan YoY sajrone 12 wulan kepungkur|Wutah pendapatan taunan sajrone rolas wulan kepungkur Akari Therapeutics, Plc (AKTX)|ENLV: Wutah pendapatan YoY sajrone 12 wulan kepungkur|Dinamika pendapatan YoY sajrone rolas wulan kepungkur QTTB (q32bio.com)|GeoVax Labs Inc (GOVX) - Wutah dodolan YoY sajrone rolas wulan kepungkur|Wutah pendapatan YoY sajrone 12 wulan kepungkur Edesa|Wutah dodolan YoY sajrone rolas wulan kepungkur iBio, Inc.|Wutah pendapatan YoY sajrone 12 wulan kepungkur carismatx.com (CARM)|Wutah dodolan YoY (TTM) XTLB|Wutah pendapatan YoY sajrone 12 wulan kepungkur Bolt Bio BOLT|Wutah dodolan YoY (TTM) HCWB (HCW Biologics)|APVO: Wutah dodolan YoY sajrone 12 wulan kepungkur|AIM - Wutah dodolan YoY sajrone rolas wulan kepungkur|ADTX - Wutah dodolan YoY (TTM)|GRI Bio (GRI) - Wutah dodolan YoY sajrone rolas wulan kepungkur|Wutah pendapatan YoY sajrone 12 wulan kepungkur XORTX Therapeutics|Wutah dodolan YoY sajrone rolas wulan kepungkur Vyome Therapeutics|Wutah dodolan YoY sajrone 12 wulan kepungkur REVB (Revelation Biosciences, Inc.)|Wutah dodolan YoY (TTM) INDP|Wutah pendapatan YoY sajrone 12 wulan kepungkur Scinai Immunotherapeutics SCNI|Wutah dodolan YoY (TTM) CALI (CalciMedica)|AFMD - Wutah pendapatan YoY sajrone 12 wulan kepungkur|ALLK: Wutah pendapatan YoY sajrone 12 wulan kepungkur|Wutah pendapatan taunan sajrone rolas wulan kepungkur HOOKIPA Pharma HOOK|IGMS: Wutah dodolan YoY (TTM)|ITOS: Owah-owahan pendapatan YoY sajrone 12 wulan kepungkur|Wutah dodolan YoY sajrone rolas wulan kepungkur Ocean Biomedical|tcbiopharm.com - Wutah dodolan taun lumaku|Wutah dodolan YoY sajrone rolas wulan kepungkur Third Harmonic Bio, Inc. (THRD)
